5-(5-fluoro-6-pyrrolidin-3-yloxy-1,3-dihydroisoindol-2-yl)-4-(trifluoromethyl)-4H-pyridazin-3-one
C17H16F4N4O2 — CID 154825723
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-(5-fluoro-6-pyrrolidin-3-yloxy-1,3-dihydroisoindol-2-yl)-4-(trifluoromethyl)-4H-pyridazin-3-one
5-(5-fluoro-6-pyrrolidin-3-yloxy-1,3-dihydroisoindol-2-yl)-4-(trifluoromethyl)-4H-pyridazin-3-one (PubChem CID 154825723) has the molecular formula C17H16F4N4O2 and a molecular weight of 384.33 g/mol. Its IUPAC name is 5-(5-fluoro-6-pyrrolidin-3-yloxy-1,3-dihydroisoindol-2-yl)-4-(trifluoromethyl)-4H-pyridazin-3-one.
Molecular Properties
| Compound Name | 5-(5-fluoro-6-pyrrolidin-3-yloxy-1,3-dihydroisoindol-2-yl)-4-(trifluoromethyl)-4H-pyridazin-3-one |
|---|---|
| PubChem CID | 154825723 |
| Molecular Formula | C17H16F4N4O2 |
| Molecular Weight | 384.33 g/mol |
| Exact Mass | 384.12 |
| IUPAC Name | 5-(5-fluoro-6-pyrrolidin-3-yloxy-1,3-dihydroisoindol-2-yl)-4-(trifluoromethyl)-4H-pyridazin-3-one |
| SMILES | O=C1N=NC=C(N2Cc3cc(F)c(OC4CCNC4)cc3C2)C1C(F)(F)F |
| InChI | InChI=1S/C17H16F4N4O2/c18-12-3-9-7-25(13-6-23-24-16(26)15(13)17(19,20)21)8-10(9)4-14(12)27-11-1-2-22-5-11/h3-4,6,11,15,22H,1-2,5,7-8H2 |
| InChIKey | OPNCWFCJDDQMCE-UHFFFAOYSA-N |
| XLogP | 2.89 |
| TPSA | 66.29 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 384.33 |
| LogP ≤ 5 | 2.89 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154825723 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.